Form 4: CME Group Director Acquires Shares Under Company Stock Plan

Phyllis M. Lockett, a Director at CME Group Inc., increased her stake in the company by acquiring 532 shares of common stock at a price of $273.03 per share.

Summary

• Phyllis M. Lockett, a Director of CME Group Inc. (CME), acquired 532 shares of the company's Class A Common Stock.
• The acquisition occurred on June 25, 2025, at a price of $273.03 per share.
• This transaction was a grant pursuant to the CME Group Director Stock Plan, as amended and restated.
• Following this acquisition, Ms. Lockett beneficially owns a total of 3,640 shares of CME Group Class A Common Stock.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director is generally viewed as a positive signal, indicating confidence in the company's prospects and aligning management interests with shareholders. This is a routine transaction under a stock plan, which adds to the positive sentiment.

Positives

• A Director, Phyllis M. Lockett, acquired additional shares in the company, which can signal confidence in the company's future performance.
• The acquisition was part of a pre-existing Director Stock Plan, indicating a structured and planned increase in insider ownership.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing reflects a routine insider transaction for CME Group, a leading global markets company that operates financial derivatives exchanges. Such transactions are common for directors receiving equity as part of their compensation or increasing their stake, and are generally viewed as a positive signal of alignment with shareholder interests within the broader financial services industry.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director can be interpreted as a positive signal of insider confidence, potentially reassuring existing shareholders and attracting new investors.

Key Dates

Keywords

CME Group, CME, SEC Form 4, Insider Transaction, Director Stock Plan, Equity Acquisition, Beneficial Ownership, Financial Services, Exchange Operator